Skip to main content
Premium Trial:

Request an Annual Quote

Shares of Accelr8, CombiMatrix Jump Sharply in May

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Accelr8 Technology and CombiMatrix climbed more than 30 percent each in May to lead the GenomeWeb Daily News Index.

The jump in Accelr8's stock price — up 37 percent for the month — continues a steady increase since the beginning of the year. Two weeks ago, the firm's shares spiked 18 percent in one day without any apparent catalyst, and it put out a statement saying that its policy is to not comment on "unusual market activity or rumors."

Accelr8 is closing in on the end of an option agreement with Novartis Vaccines and Diagnostics to negotiate the terms of a development pact regarding its BACcel system. That agreement had been extended to June 30, 2011.

Likewise, shares of CombiMatrix climbed around 33 percent in May, and its stock also jumped sharply one day last week despite an unclear reason for that increase. Earlier in the month, it reported $912,000 in first-quarter revenues, an 11 percent increase year over year.

Molecular diagnostics firm Vermillion also had a strong month, rising 24 percent. Its stock rose after the firm announced that diagnostic industry veteran Bruce Huebner had been appointed to its board of directors and would lead a special committee to evaluate the current sales and marketing strategy of Vermillion's OVA1 test for ovarian cancer.

Nanosphere had the steepest drop among the stocks in the Index that lost value for the month, falling around 14 percent. The firm's shares dropped earlier in the month when it announced a public offering of its common stock.

Overall, the GWDN Index gained 1 percent in May. In comparison, the Dow Jones Industrial Average fell 2 percent, and the Nasdaq declined 1 percent, while the Nasdaq Biotech Index gained nearly 2 percent.

Ed. Note: Celera was removed from the Index after it was acquired by Quest Diagnostics and its shares stopped trading on the Nasdaq.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.